Adeno-associated viral vectors comprise the majority of recent gene therapy development programs due to their broad tissue-tropism and relatively low immunogenicity. Recent gene therapy approvals, ...
Five main classes of clinically applicable virus vector have been engineered over recent years to improve the efficiency and safety of gene delivery. Hybrid vectors that combine the properties of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results